CSAD and glioblastoma: Additionally, homocysteic acid (an inhibitor of cysteine sulfinic acid decarboxylase — hypotaurine production) can inhibit the proliferation of glioblastoma cell lines, and some in vivo studies have confirmed that hypotaurine could be a targetable oncometabolite in glioblastomas [49, 50].